Skip to main content
  1. Home
  2. Emerging Tech
  3. News

This creepy snake-like robot is designed to fix equipment on the ocean floor

Add as a preferred source on Google

James Cameron may have an affinity for deep sea exploration, but the ocean can be a dark and forbidding place where few people care to venture. Much of the world’s internet and international phone communications are enabled by submarine cables. Offshore oil rigs need constant monitoring. And with scientists looking to the ocean as a source of sustainable energy, there’s an increasing need to maintain deep sea equipment. Enter Eelume, a snakelike robot built to do just that

 

Eelume may look like a predator from an undersea horror film, but the robot wasn’t conceived to be a nightmare. A partnership between engineers from the Norwegian University of Science and Technology, Konsberg Maritime, and Statoil, Eelume’s thin and flexible form enables it to reach areas that are too confined for conventional remote operated vehicles (ROVs). Most ROVs tend to be big and bulky, making them costly and impractical to use in quick fixes. Even in more comprehensive jobs, ROVs’ size can keep them from accessing certain areas. Eelume is designed as a cost-effective alternative for tackling small maintenance and light intervention operations such as visual inspections, cleaning, and adjusting valves on underwater equipment.

Recommended Videos

Eelume is a good example of how new technology and innovation contributes to cost reduction,” Statoil’s CTO, Elisabeth Kirkland Kvalheim, says on her company’s website. “Instead of using large and expensive vessels for small jobs, we now introduce a flexible robot acting as a self going janitor on the seabed.”

The robot mechanic can move through the water by either slithering like a snake or using a set of propellers attached to its tail. The machines are currently tethered by a power chord but Eelume’s creators hope to free future versions as the technology advances. Someday they’ll be permanently installed on the ocean floor, where they’ll perform planned and on-demand operations.

Dyllan Furness
Former Contributor
Dyllan Furness is a freelance writer from Florida. He covers strange science and emerging tech for Digital Trends, focusing…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more